 |
|
|
 |
|
Hawaii Anesthesiology Update 2008
August 4-8, 2008
The Fairmont Orchid, Hawaii (Big Island)
An Intensive Review of the Specialty of Pain Medicine: A Pain Board Oriented Review Course
Aug 23-28, 2008
Chicago City Centre Hotel, Chicago, IL
The Annual Fall Nurse Anesthetist Review and Update and Regional Anesthesia Hands-on Workshop
Dec 1-6, 2008
Westin Riverwalk, San Antonio, TX
|
|
» View All Meetings
|
|
|
|
 |
 |
 |
 |
Thursday, August 28, 2008 |
|
|
|
|
|
|
Home : Professionals : CME/CE/CPE Slide Presentations
|
|
|
State Policies Affecting Pain Management: Relevance, Progress & Next Steps
Release Date: July 2007
Expiration Date: July 31, 2008
 
This program is sponsored by the Dannemiller Memorial Educational Foundation.
Supported by an educational grant from Purdue Pharma LP.
NEEDS STATEMENT
Federal and state policy regarding opioids needs to achieve a balance between efforts to control drug abuse and maintain drug availability for legitimate medical purposes. Federal controlled substances law affirms the essential medical value of drugs that are controlled substances. Imprecise legal definition of terms allows patients to be confused with addicts. In addition, some states require physicians to report opioid-dependent patients to the government. Recommendations are offered to revise state laws and to improve communication between health care professionals and regulators.
EDUCATIONAL OBJECTIVES
Upon completion of the enduring materials, participants should be able to:
- Define quality of and disparities in state pain policies.
- Describe how state policies have changed over time.
- Describe how pain treatment for the same patient could differ under current state policies.
- Examine methods being used to improve pain policies.
TARGET AUDIENCE
Physicians, psychologists and nurses interested in pain management, attendees of the annual APS meeting.
PHYSICIAN ACCREDITATION
The Dannemiller Memorial Educational Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
PHYSICIAN DESIGNATION OF CREDIT
The Dannemiller Memorial Educational Foundation designates this educational activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
NURSING CREDIT
The Dannemiller Memorial Educational Foundation is an approved provider of the California Board of Registered Nursing. Provider approved by the California Board of Registered Nursing, Provider Number 4229 for 1.2 contact hours.
RNs outside California must verify with their licensing agency for approval of this course.
PHARMACIST CREDIT
 
Purdue University is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This is a continuing education activity of Purdue, an equal access/equal opportunity university. To receive the 1 contact hour of continuing education credit, pharmacists must attend the entire program and complete all registration and evaluations at its conclusion. Program #018-999-06-066-H03. Approval is valid from the initial release date of July 1, 2007. Expiration date is July 31, 2008.
METHOD OF PARTICIPATION
This online CME activity should take approximately 1 hour to complete. This activity consists of three slide presentations. To complete this activity the participant should, in order, read the CME information, view each slide presentation in its entirety, go to the link provided at the end of the activity to take the posttest, complete the registration and evaluation, and print the CME certificate. The evaluation form provides each participant with the opportunity to comment on the quality of the instructional process, the perception of enhanced professional effectiveness, the perception of commercial bias, and his or her views on future educational needs. To receive credit for this activity, follow the instructions provided on the posttest. If you have questions, you can contact the Dannemiller Foundation at editor@dannemiller.com. The activity expires on July 31, 2008 and no credit will be awarded after this date.
PRESENTATIONS/FACULTY
Review Results Pain and Policy Studies Group Research
Aaron M. Gilson, PhD
Associate Scientist, Associate Director for U.S.
Policy Research
Pain & Policy Studies Group
Ways to Improve State Pain Policies
William Marcus, JD
Lecturer, Instructor and Consultant pharmacy law, controlled substances, pain management and administrative law
University of California San Diego
Case Presentations- How Professional Practice and Patient Care Could Vary Depending on State Pain Policies
Howard A. Heit, MD, FACP, FASAM
Board Certified in Internal Medicine and Gastroenterology/Hepatology
Certified in Addiction Medicine and a Medical Review Officer
Chronic Pain Specialist
Assistant Clinical Professor, Georgetown University
DISCLOSURE
In accordance with the Accreditation Council for Continuing Medical Education (ACCME), the Dannemiller Memorial Educational Foundation requires that any person who is in a position to control the content of a CME activity must disclose all relevant financial relationships they have with a commercial interest. Accordingly;
Dr. Gilson is an investigator for Purdue Pharma and Endo Pharmaceuticals.
Dr. Heit is a speaker for Purdue Pharma, Cephalon and King. He is also a consultant for Purdue, Cephalon, Endo Pharmaceuticals, Alpharma, King and Abbott.
Mr. Marcus has nothing to disclose.
The Dannemiller staff who were involved in the development of this activity have no financial relationships with any commercial interests that are relevant to this activity.
To resolve identified conflicts of interest, the educational content was fully peer reviewed by a physician member of the Dannemiller Clinical Content Review Committee who has nothing to disclose. The resulting certified activity was found to provide educational content that is current, evidence-based, and commercially balanced.
DISCLAIMER
The content and views presented herein are those of the authors and do not necessarily reflect those of the Dannemiller Memorial Educational Foundation or Purdue Pharma. This material is prepared based upon a review of multiple sources of information, but it is not exhaustive of the subject matter. Therefore, healthcare professionals and other individuals should review and consider other publications and materials on the subject matter before relying solely on the information contained within this educational activity.
DISCLOSURE OR UNLABELED OR INVESTIGATIONAL DRUGS
This educational activity may contain discussion of published an/or investigational uses of agents that are not indicated by the Food and Drug Administration (FDA). The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.
The publishers reserve copyright on all published materials, and such materials may not be reproduced in any form without the permission of Dannemiller Memorial Educational Foundation. This slide presentation was developed and produced and is sponsored by the Dannemiller Memorial Educational Foundation.
» Click Here To Begin
|
|
|
|
